Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine for painful diabetic neuropathy
IRCT20180404039187N5Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of memantine in diabetic neuropathy (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoints: Fasting blood sugar, Glycosylated hemoglobin (HbA1c) and 4 more. Started May 2019; status: completed.
02
Drugs
memantine
03
Conditions
diabetic neuropathy
Beyond the preview
Go deeper on IRCT20180404039187N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180404039187N5.